SOLV Q2 2024 Earnings — Solventum Corporation Revenue & Financial Results | Market Cap Arena

SOLVSolventum Corporation

$12B

Q2 2024 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$2.1B+0.2% YoY

Gross Profit

$1.1B54.6% margin

Operating Income

$244M11.7% margin

Net Income

$89M4.3% margin

EPS (Diluted)

$0.51

QoQ Revenue Growth

+3.2%

Cash Flow

Operating Cash Flow

$355M

Free Cash Flow

$297M

Stock-Based Comp.

$56M

Balance Sheet

Total Assets

$14.6B

Total Liabilities

$11.7B

Stockholders' Equity

$2.9B

Cash & Equivalents

$897M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.1B	$2.1B	+0.2%
Gross Profit	$1.1B	$1.2B	-4.4%
Operating Income	$244M	$417M	-41.5%
Net Income	$89M	$321M	-72.3%

Revenue Segments

Product

$1.6B100%